STAT3 is both overexpressed and activated primarily as a function of autocrine secretion of IL-6/IL-10 by tumor cells [18], a survival mechanism that can be promoted in the context of mutations that drive NF-κB activation and subsequent NF-κB-mediated cytokine expression [19]. The gene discussed is NFKB1; the disease is neoplasm.